The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 21, 2017

Filed:

Jun. 17, 2011
Applicants:

Gregory Alan Lazar, Arcadia, CA (US);

John R. Desjarlais, Pasadena, CA (US);

Philip W. Hammond, Sierra Madre, CA (US);

David F. Carmichael, Monrovia, CA (US);

Bao-lu Chen, San Ramon, CA (US);

Seung Y. Chu, Upland, CA (US);

Sher Bahadur Karki, Pasadena, CA (US);

Lori Kunkel, San Francisco, CA (US);

Inventors:

Gregory Alan Lazar, Arcadia, CA (US);

John R. Desjarlais, Pasadena, CA (US);

Philip W. Hammond, Sierra Madre, CA (US);

David F. Carmichael, Monrovia, CA (US);

Bao-lu Chen, San Ramon, CA (US);

Seung Y. Chu, Upland, CA (US);

Sher Bahadur Karki, Pasadena, CA (US);

Lori Kunkel, San Francisco, CA (US);

Assignee:

Xencor, Inc., Monrovia, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2878 (2013.01); C07K 2317/24 (2013.01); C07K 2317/72 (2013.01); C07K 2317/732 (2013.01);
Abstract

An antibody that targets CD30, wherein the antibody comprises at least one modification relative to a parent antibody and the antibody binds with altered affinity to an FcγR or alters effector function as compared to the parent antibody. Also disclosed are methods of using the anti-CD30 antibody.


Find Patent Forward Citations

Loading…